Перейти к основному содержанию
Phesgo (Pertuzumab / Trastuzumab) 600 mg – Targeted Therapy for HER2-Positive Breast Cancer  Phesgo (Pertuzumab/Trastuzumab) - Macrocare Health Blog

Phesgo (Pertuzumab / Trastuzumab) 600 mg – Targeted Therapy for HER2-Positive Breast Cancer Phesgo (Pertuzumab/Trastuzumab)

Phesgo (Pertuzumab/Trastuzumab) Phesgo (Pertuzumab / Trastuzumab) is a targeted biologic therapy used in the treatment of HER2-positive breast cancer. It helps slow cancer cell growth and improve treatment outcomes.

 

What is Phesgo?

Phesgo combines two targeted therapies:

  • Pertuzumab
  • Trastuzumab

The medication works by targeting the HER2 protein, which is overexpressed on the surface of certain breast cancer cells.

It helps to:

  • Slow the growth of cancer cells
  • Prevent tumor progression and spread
  • Enhance treatment effectiveness when used with chemotherapy or other therapies

In simple terms:
It is a targeted treatment that blocks the HER2 receptor responsible for the growth of certain breast cancers.

 

Indications

Phesgo (Pertuzumab / Trastuzumab) is used in:

  • Early-stage HER2-positive breast cancer
  • Advanced or metastatic HER2-positive breast cancer
  • Treatment protocols before or after surgery
  • Combination regimens with other cancer therapies as prescribed

 

Dosage and Administration

  • Dose: 600 mg according to the treatment protocol
  • Administered as a subcutaneous injection
  • Given by a specialized healthcare team
  • Treatment schedule varies depending on the prescribed regimen

 

Common Side Effects

May include:

  • Fatigue
  • Nausea or diarrhea
  • Hair loss when combined with chemotherapy
  • Injection site reactions
  • Low blood cell counts

Rarely: heart-related side effects requiring regular monitoring.

 

Monitoring During Treatment

Patients on Phesgo require:

  • Cardiac function monitoring
  • Assessment of tumor response
  • Complete blood count (CBC) monitoring
  • Evaluation of overall patient condition

 

Availability & How to Access Treatment

Phesgo (Pertuzumab/Trastuzumab) is available through Macrocare’s approved partners.

You can now request and access the medication easily through us.

WhatsApp contact for medication requests:
Click here

 

Phesgo (Pertuzumab/Trastuzumab) Phesgo (Pertuzumab / Trastuzumab) 600 mg is a targeted biologic therapy for HER2-positive breast cancer that works by blocking HER2 receptors and improving disease control.

 

Medical Disclaimer:
This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.

Другие статьи

Введите номер мобильного телефона

Пожалуйста, укажите ваш номер телефона, чтобы мы могли связаться с вами и узнать о вашей проблеме со здоровьем.

Конфиденциальность защищена: ваша медицинская и личная информация хранится полностью конфиденциально и защищена с использованием отраслевых стандартов защиты.

СВЯЗАТЬСЯ С НАМИ

Свяжитесь с нами

Пожалуйста, укажите ваш номер телефона, чтобы мы могли связаться с вами и узнать о вашей проблеме со здоровьем.